Real-time enrollment status for this malignant solid neoplasm clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:36 AM UTC
| NCT Number | NCT06295367 |
| Recruiting Status | Recruiting |
| Condition | Malignant Solid Neoplasm |
| Phase | Clinical Trial |
| Target Enrollment | 760 participants |
| Active Locations | 384 sites in the US |
| Sponsor | ECOG-ACRIN Cancer Research Group |
| Last Updated on CT.gov | June 18, 2026 (3 weeks ago) |
As of July 13, 2026: Clinical trial NCT06295367 is currently recruiting participants. This clinical trial study for malignant solid neoplasm is actively seeking new participants at 384 locations across the United States. The study is sponsored by ECOG-ACRIN Cancer Research Group. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06295367 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 384 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06295367 was last updated 3 weeks ago (June 18, 2026). HelloStudys verifies this status automatically.